<SEC-DOCUMENT>0001213900-19-005210-index.html : 20190329
<SEC-HEADER>0001213900-19-005210.hdr.sgml : 20190329
<ACCEPTANCE-DATETIME>20190329133938
ACCESSION NUMBER:		0001213900-19-005210
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20190327
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190329
DATE AS OF CHANGE:		20190329

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			IMMUCELL CORP /DE/
		CENTRAL INDEX KEY:			0000811641
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				010382980
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-12934
		FILM NUMBER:		19715426

	BUSINESS ADDRESS:	
		STREET 1:		56 EVERGREEN DR
		CITY:			PORTLAND
		STATE:			ME
		ZIP:			04103
		BUSINESS PHONE:		2078782770

	MAIL ADDRESS:	
		STREET 1:		56 EVERGREEN DRIVE
		CITY:			PORTLAND
		STATE:			ME
		ZIP:			04103
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>f8k032719_immucellcorp.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: f8k032719_immucellcorp.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-1.1 <SEQUENCE>2 <FILENAME>f8k032719ex1-1_immucell.htm <DESCRIPTION>UNDERWRITING AGREEMENT BETWEEN THE COMPANY AND CRAIG-HALLUM CAPITAL GROUP LLC, DATED MARCH 27, 2019 <TEXT> Document 2 - file: f8k032719ex1-1_immucell.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>3 <FILENAME>f8k032719ex5-1_immucell.htm <DESCRIPTION>OPINION OF PIERCE ATWOOD LLP <TEXT> Document 3 - file: f8k032719ex5-1_immucell.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>4 <FILENAME>f8k032719ex99-1_immucell.htm <DESCRIPTION>PRESS RELEASE OF IMMUCELL CORPORATION, DATED MARCH 26, 2019 <TEXT> Document 4 - file: f8k032719ex99-1_immucell.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>5 <FILENAME>f8k032719ex99-2_immucell.htm <DESCRIPTION>PRESS RELEASE OF IMMUCELL CORPORATION, DATED MARCH 27, 2019 <TEXT> Document 5 - file: f8k032719ex99-2_immucell.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>6 <FILENAME>f8k032719ex99-3_immucell.htm <DESCRIPTION>PRESS RELEASE OF IMMUCELL CORPORATION, DATED MARCH 29, 2019 <TEXT> Document 6 - file: f8k032719ex99-3_immucell.htm
</DOCUMENT> </SEC-DOCUMENT>